✦ LIBER ✦

Racial Differences Among High-Risk Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes (Results from the SYNERGY Trial)

✍ Scribed by Melvin R. Echols; Kenneth W. Mahaffey; Anindita Banerjee; Karen S. Pieper; Amanda Stebbins; Alexandra Lansky; Mauricio G. Cohen; Eric Velazquez; Renato Santos; L. Kristin Newby; Enrique P. Gurfinkel; Luigi Biasucci; James J. Ferguson; Robert M. Califf

Book ID: 113443430
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 134 KB
Volume: 99
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2006.08.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Obesity in patients with non-ST-segment

Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial

✍ Kenneth W. Mahaffey; Simon T. Tonev; Sarah A. Spinler; Glenn N. Levine; Richard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Relationship between renal function and

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGY

✍ Sarah A. Spinler; Kenneth W. Mahaffey; Dianne Gallup; Glenn N. Levine; James J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Atrial fibrillation and mortality among

Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial

✍ Sana M. Al-Khatib; Karen S. Pieper; Kerry L. Lee; Kenneth W. Mahaffey; Judith S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Exploring the role of enoxaparin in the

Exploring the role of enoxaparin in the management of high-risk patients with non–ST-elevation acute coronary syndromes: The SYNERGY trial

✍ Kenneth W. Mahaffey; James J. Ferguson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Enoxaparin vs. unfractionated heparin in

Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-Segment elevation acute coronary syndromes managed with an intended early invasive strategy—primary results of the SYNERGY randomized trial

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Prediction of One-Year Survival in High-

Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial

✍ Kenneth W. Mahaffey; Qinghong Yang; Karen S. Pieper; Elliott M. Antman; Harvey D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB